0001193125-20-221618 Sample Contracts

] Shares KYMERA THERAPEUTICS, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT

Underwriting Agreement • August 17th, 2020 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Underwriting Agreement
• Filed
  August 17th, 2020
• Company
  Kymera Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

KYMERA THERAPEUTICS, INC. FORM OF DIRECTOR INDEMNIFICATION AGREEMENT

Director Indemnification Agreement • August 17th, 2020 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Director Indemnification Agreement
• Filed
  August 17th, 2020
• Company
  Kymera Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Indemnification Agreement (“Agreement”) is made as of [________] by and between Kymera Therapeutics, Inc., a Delaware corporation (the “Company”), and [Director] (“Indemnitee”).

COMMON STOCK PURCHASE AGREEMENT

Common Stock Purchase Agreement • August 17th, 2020 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Common Stock Purchase Agreement
• Filed
  August 17th, 2020
• Company
  Kymera Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of [•], 2020, by and between Kymera Therapeutics, Inc., a Delaware corporation (“Company”), and Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (“Purchaser”).